Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

Technology appraisal guidance
Reference number: TA261
Published: 25 July 2012

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix B - GE proposal paper April 2015

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix B - GE proposal paper April 2015

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix B - GE proposal paper April 2015
12 May 2015
(380.47 Kb 50 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 11 May 2015